{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:09:44Z","timestamp":1789265384620,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.pain.2010.04.013","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T04:45:44Z","timestamp":1274417144000},"page":"420-427","source":"Crossref","is-referenced-by-count":132,"title":["The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy"],"prefix":"10.1097","volume":"150","author":[{"given":"Ralf","family":"Baron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Freynhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"T\u00f6lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kem","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210112","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1007\/s00586-006-1072-1","article-title":"COST B13 working group on guidelines for chronic low back pain. Chapter 4. European guidelines for the management of chronic nonspecific low back pain.","volume":"15","author":"Airaksinen","year":"2006","journal-title":"Eur Spine J"},{"key":"R2-12-20210112","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1526-4637.2007.00332.x","article-title":"The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.","volume":"8","author":"Arnold","year":"2007","journal-title":"Pain Med"},{"key":"R3-12-20210112","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00132-004-0645-0","article-title":"How neuropathic is sciatica? The mixed pain concept.","volume":"33","author":"Baron","year":"2004","journal-title":"Orthopade"},{"key":"R4-12-20210112","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1523\/JNEUROSCI.0356-09.2009","article-title":"The increased trafficking of the calcium channel subunit 2-1 to presynaptic terminals in neuropathic pain is inhibited by the 2 ligand pregabalin.","volume":"29","author":"Bauer","year":"2009","journal-title":"J Neurosci"},{"key":"R5-12-20210112","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2146\/ajhp060371","article-title":"Pregabalin: an antiepileptic agent useful for neuropathic pain.","volume":"64","author":"Blommel","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"R6-12-20210112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","article-title":"American Pain Society, American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain SocietyAmerican College of Physicians clinical practice guideline.","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"R7-12-20210112","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-147-7-200710020-00006","article-title":"Clinical Efficacy Assessment Subcommittee of the American College of Physicians, American College of Physicians, American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society.","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"R8-12-20210112","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pain.2008.02.027","article-title":"Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.","volume":"136","author":"Crofford","year":"2008","journal-title":"Pain"},{"key":"R9-12-20210112","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"R10-12-20210112","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.jcp.0000084032.22282.ff","article-title":"A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.","volume":"23","author":"Feltner","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R11-12-20210112","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11916-009-0032-y","article-title":"The evaluation of neuropathic components in low back pain.","volume":"13","author":"Freynhagen","year":"2009","journal-title":"Curr Pain Headache Rep"},{"key":"R12-12-20210112","doi-asserted-by":"crossref","first-page":"b3002","DOI":"10.1136\/bmj.b3002","article-title":"Diagnosis and management of neuropathic pain.","volume":"339","author":"Freynhagen","year":"2009","journal-title":"BMJ"},{"key":"R13-12-20210112","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/ALN.0b013e31818dac9c","article-title":"Gabapentin acts within the locus coeruleus to alleviate neuropathic pain.","volume":"109","author":"Hayashida","year":"2008","journal-title":"Anesthesiology"},{"key":"R14-12-20210112","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the 2 ligand gabapentin.","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R15-12-20210112","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain.","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"key":"R16-12-20210112","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jpain.2005.08.002","article-title":"Topiramate in chronic lumbar radicular pain.","volume":"6","author":"Khoromi","year":"2005","journal-title":"J Pain"},{"key":"R17-12-20210112","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1124\/jpet.102.041574","article-title":"Injury type-specific calcium channel 2-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin.","volume":"303","author":"Luo","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R18-12-20210112","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","article-title":"Upregulation of dorsal root ganglion 2 calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.","volume":"21","author":"Luo","year":"2001","journal-title":"J Neurosci"},{"key":"R19-12-20210112","first-page":"483","article-title":"Antidepressants and antiepileptic drugs for chronic non-cancer pain.","volume":"71","author":"Maizels","year":"2005","journal-title":"Am Fam Physician"},{"key":"R20-12-20210112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1163\/156856901753420945","article-title":"Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study.","volume":"13","author":"McCleane","year":"2001","journal-title":"Pain Clinic"},{"key":"R21-12-20210112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain.","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"key":"R22-12-20210112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/pgmj.2004.024737","article-title":"Placebo.","volume":"81","author":"McQuay","year":"2005","journal-title":"Postgrad Med J"},{"key":"R23-12-20210112","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1002\/art.23056","article-title":"The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period.","volume":"56","author":"Pavelka","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R24-12-20210112","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/rheumatology\/41.12.1346","article-title":"Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.","volume":"41","author":"Pincus","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R25-12-20210112","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.sleep.2009.01.009","article-title":"The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome.","volume":"10","author":"Russell","year":"2009","journal-title":"Sleep Med"},{"key":"R26-12-20210112","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"R27-12-20210112","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ejpain.2008.12.003","article-title":"Modelling the prevalence and cost of back pain with neuropathic components in the general population.","volume":"13","author":"Schmidt","year":"2009","journal-title":"Eur J Pain"},{"key":"R28-12-20210112","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.euroneuro.2008.01.004","article-title":"Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.","volume":"18","author":"Stein","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"R29-12-20210112","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ncl.2007.01.008","article-title":"Lumbosacral radiculopathy.","volume":"25","author":"Tarulli","year":"2007","journal-title":"Neurol Clin"},{"key":"R31-12-20210112","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research.","volume":"271","author":"Turner","year":"1994","journal-title":"JAMA"},{"key":"R32-12-20210112","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1163\/156856903767650718","article-title":"The effectiveness of gabapentin in patients with chronic radiculopathy.","volume":"15","author":"Yildirim","year":"2003","journal-title":"Pain Clinic"},{"key":"R33-12-20210112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1358\/dot.2005.41.8.910482","article-title":"Pregabalin: a new agent for the treatment of neuropathic pain.","volume":"41","author":"Zareba","year":"2005","journal-title":"Drugs Today (Barc)"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1016\/j.pain.2010.04.013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:22:22Z","timestamp":1786040542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-201009000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2010.04.013","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}